Deep in our cells, a wide range of processes are occurring constantly. These cellular processes rely on enzymes to act as catalysts and set off a series of molecular interactions. There are still many ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...

Obesity is an independent driver of cardiovascular disease (CVD), mediated through adverse haemodynamic loading, insulin resistance, systemic inflammation, endothelial dysfunction and prothrombotic ...

Saturated fats are often discussed mainly for their role in raising LDL cholesterol, but research shows their metabolic ...

Interest in the use and impacts of glucagon-like peptide-1 receptor agonists in rheumatology has exploded over the past year, a trend that appeared to crescendo at ACR Convergence 2025. There, ...

Willpower is not purely a personality trait. Aging, obesity, insulin resistance, and inflammation may impair frontal brain ...

Although a growing body of evidence suggests a positive impact of GLP-1 receptor agonists in treating MS, questions of health ...

Physicians must deploy specific tools in specific ways at specific times — adding to the time-consuming treatment costs.

This narrative review examines how micro- and nanoplastics may contribute to oxidative stress, inflammation, and metabolic ...

New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, ...

Diabetes mellitus, particularly type 2 diabetes, is associated with an increased risk of several malignancies, raising important questions at the interface ...

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much ...